BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 25117129)

  • 1. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
    JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
    Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.
    Hoff G; Grotmol T; Skovlund E; Bretthauer M;
    BMJ; 2009 May; 338():b1846. PubMed ID: 19483252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.
    Atkin W; Wooldrage K; Parkin DM; Kralj-Hans I; MacRae E; Shah U; Duffy S; Cross AJ
    Lancet; 2017 Apr; 389(10076):1299-1311. PubMed ID: 28236467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
    Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
    J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
    Schoen RE; Pinsky PF; Weissfeld JL; Yokochi LA; Church T; Laiyemo AO; Bresalier R; Andriole GL; Buys SS; Crawford ED; Fouad MN; Isaacs C; Johnson CC; Reding DJ; O'Brien B; Carrick DM; Wright P; Riley TL; Purdue MP; Izmirlian G; Kramer BS; Miller AB; Gohagan JK; Prorok PC; Berg CD;
    N Engl J Med; 2012 Jun; 366(25):2345-57. PubMed ID: 22612596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
    Segnan N; Armaroli P; Bonelli L; Risio M; Sciallero S; Zappa M; Andreoni B; Arrigoni A; Bisanti L; Casella C; Crosta C; Falcini F; Ferrero F; Giacomin A; Giuliani O; Santarelli A; Visioli CB; Zanetti R; Atkin WS; Senore C;
    J Natl Cancer Inst; 2011 Sep; 103(17):1310-22. PubMed ID: 21852264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
    Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.
    Atkin WS; Edwards R; Kralj-Hans I; Wooldrage K; Hart AR; Northover JM; Parkin DM; Wardle J; Duffy SW; Cuzick J;
    Lancet; 2010 May; 375(9726):1624-33. PubMed ID: 20430429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).
    Bretthauer M; Gondal G; Larsen K; Carlsen E; Eide TJ; Grotmol T; Skovlund E; Tveit KM; Vatn MH; Hoff G
    Scand J Gastroenterol; 2002 May; 37(5):568-73. PubMed ID: 12059059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
    Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø
    Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
    Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
    Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Holme Ø; Bretthauer M; Fretheim A; Odgaard-Jensen J; Hoff G
    Cochrane Database Syst Rev; 2013 Oct; 2013(9):CD009259. PubMed ID: 24085634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial.
    Senore C; Riggi E; Armaroli P; Bonelli L; Sciallero S; Zappa M; Arrigoni A; Casella C; Crosta C; Falcini F; Ferrero F; Fracchia M; Giuliani O; Risio M; Russo AG; Visioli CB; Rosso S; Segnan N;
    Ann Intern Med; 2022 Jan; 175(1):36-45. PubMed ID: 34748376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.
    Click B; Pinsky PF; Hickey T; Doroudi M; Schoen RE
    JAMA; 2018 May; 319(19):2021-2031. PubMed ID: 29800214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Options for screening for colorectal cancer.
    Atkin W
    Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
    Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
    BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.